BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2885357)

  • 21. Inhibition of the cutaneous response to histamine by H1-blocking agents. Quantitative evaluation of microvascular changes in the skin after histamine challenge and a comparison of the effects of a single intake of cetirizine and terfenadine.
    Van Neste D; Rihoux JP
    Skin Pharmacol; 1988; 1(3):192-9. PubMed ID: 2908486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine.
    Goetz DW; Jacobson JM; Murnane JE; Reid MJ; Repperger DW; Goodyear C; Martin ME
    J Allergy Clin Immunol; 1989 Sep; 84(3):316-22. PubMed ID: 2570798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double blind trial of terfenadine and placebo in hay fever using a substitution technique for non-responders.
    Kagan G; Dabrowicki E; Huddlestone L; Kapur TR; Wolstencroft P
    J Int Med Res; 1980; 8(6):404-7. PubMed ID: 6108264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical studies of terfenadine in seasonal allergic rhinitis.
    Brandon ML; Weiner M
    Arzneimittelforschung; 1982; 32(9a):1204-5. PubMed ID: 6129869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of terfenadine at two dose levels in the management of hayfever.
    Stern MA; Rosenberg RM; Smith R; Fidler C
    Br J Clin Pract; 1990 Sep; 44(9):359-63. PubMed ID: 1977464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter, double-blind, placebo-controlled trial of terfenadine suspension in the treatment of fall-allergic rhinitis in children.
    Guill MF; Buckley RH; Rocha W; Kemp JP; Segal AT; Shirley LR; Tinkelman DG; Shaath-Schwen Z; Dietrich KK; Wille LJ
    J Allergy Clin Immunol; 1986 Jul; 78(1 Pt 1):4-9. PubMed ID: 2873161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some clinical pharmacological studies with terfenadine, a new antihistamine drug.
    Kulshrestha VK; Gupta PP; Turner P; Wadsworth J
    Br J Clin Pharmacol; 1978 Jul; 6(1):25-9. PubMed ID: 27203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Terfenadine, safety and tolerance in controlled clinical trials.
    Barlow JL; Beitman RE; Tsai TH
    Arzneimittelforschung; 1982; 32(9a):1215-7. PubMed ID: 6129874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry.
    Orgel HA; Meltzer EO; Kemp JP; Ostrom NK; Welch MJ
    Ann Allergy; 1991 Mar; 66(3):237-44. PubMed ID: 1672493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-centre double-blind comparison of terfenadine once daily versus twice daily in patients with hay fever.
    Henauer S; Hugonot L; Hugonot R; Kurzeja A; Gastpar H; Rauch-Riedelsheimer B; Beaumont D; Köhler M
    J Int Med Res; 1987; 15(4):212-23. PubMed ID: 2888692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of terfenadine, diphenhydramine, and placebo on skills performance.
    Moskowitz H; Burns M
    Cutis; 1988 Oct; 42(4A):14-8. PubMed ID: 2903812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative trial of two dose regimens of terfenadine in patients with hay fever.
    Murphy-O'Connor JC; Renton RL; Westlake DM
    J Int Med Res; 1984; 12(6):333-7. PubMed ID: 6151528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of SK&F 104353, a leukotriene receptor antagonist, on the bronchial responses to histamine in subjects with asthma: a comparative study with terfenadine.
    Dinh Xuan AT; Regnard J; Similowski T; Rey J; Marsac J; Lockhart A
    J Allergy Clin Immunol; 1990 May; 85(5):865-71. PubMed ID: 1970584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine.
    Goetz DW; Jacobson JM; Apaliski SJ; Repperger DW; Martin ME
    Ann Allergy; 1991 Oct; 67(4):448-54. PubMed ID: 1683192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
    Shall L; Newcombe RG; Lush M; Marks R
    Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of histamine-H1 receptor antagonism with terfenadine on concentration-related AMP-induced bronchoconstriction in asthma.
    Phillips GD; Polosa R; Holgate ST
    Clin Exp Allergy; 1989 Jul; 19(4):405-9. PubMed ID: 2569356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terfenadine once daily in chronic urticaria. A multi-centre double-blind comparison of terfenadine once daily versus twice daily.
    Allergy; 1989 Sep; 44(7):447-52. PubMed ID: 2573286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy.
    McTavish D; Goa KL; Ferrill M
    Drugs; 1990 Apr; 39(4):552-74. PubMed ID: 1972050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose study of the effect of terfenadine on theophylline absorption and disposition.
    Fitzsimmons WE; Luskin SS; MacLeod CM; Luskin AT
    Ann Allergy; 1989 Mar; 62(3):213-4. PubMed ID: 2564266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory activity of terfenadine on histamine-induced skin wheals in man.
    Hüther KJ; Renftle G; Barraud N; Burke JT; Koch-Weser J
    Eur J Clin Pharmacol; 1977 Nov; 12(3):195-9. PubMed ID: 22436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.